What happens if China wins the Covid-19 vaccine race? U.S. prestige could falter, the administration could take deadly risks, the world will have to rethink its alliances — and those are just a few of the possibilities.
currently in Phase III trials will prove safe and effective at fighting the coronavirus. Of those eight candidates, four are Chinese, three are funded by the Trump administration’s Operation Warp Speed and one comes from Australia. Some experts already worry some of the most publicized candidates are overhyped.
Which means Fidler’s fear isn’t so far-fetched. It’s very possible a Chinese vaccine could be the first to succeed in Phase III trials. If Warp Speed contenders fail, the U.S. could be perhaps six to eight months behind in developing one. What happens then? Governments and drug makers are all racing to be first to develop a Covid-19 vaccine. Left: A volunteer receives a Covid-19 vaccine for a vaccine study implemented under the U.S. government’s Operation Warp Speed program. Right: The volunteer gets her blood drawn. | Joe Raedle/Getty Images
Health and national security experts envision, in that case, the future unfolding like a kind of “choose your own nightmare” narrative, each potential pathway leading to geopolitical quagmires and thorny scientific traps. What if China refuses to give a safe vaccine to the United States, instead using it as a bargaining chip to combat U.S. power? What if the Trump administration, or a Biden administration, refuses to accept it? What if a Chinese “victory” pressures the U.S.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Explainer: How common cold viruses are being used in vaccines from Russia, ChinaThe modified common cold viruses behind high-profile COVID-19 vaccine candidates from China's CanSino Biologics and Russia's Gamaleya Institute have been studied for decades, but are still not widely used.
Weiterlesen »
Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss COVID-19 Vaccines'The US_FDA announced that a public meeting of the Vaccines and Related Biological Products Advisory Committee will be held on Oct. 22, 2020, to discuss the general matter of the development, authorization, and/or licensure of [covid19 vaccines].'
Weiterlesen »
COVID-19 vaccine diplomacy: Mexico courts allies across ideological spectrumMexico is pressing ahead with an effort to forge COVID-19 vaccine alliances across a wide ideological spectrum of countries from France to Cuba as a World Health Organization (WHO) vaccine initiative will fall short of its needs.
Weiterlesen »
Scientists see downsides to top COVID-19 vaccines from Russia, ChinaHigh-profile COVID-19 vaccines developed in Russia and China share a potential shortcoming: They are based on a common cold virus to which many people have been exposed, potentially limiting their effectiveness, some experts say
Weiterlesen »
FDA: COVID Vaccine Could Be Given Before Tests EndEmergency use authorization or approval for a COVID-19 vaccine before Phase 3 clinical trials are complete could be considered by the U.S. Food and Drug Administratio
Weiterlesen »